Skip to main content

Month: June 2021

MetaBank’s Christopher Soupal Named Division President, Head of Commercial Finance

SIOUX FALLS, S.D., June 29, 2021 (GLOBE NEWSWIRE) — MetaBank®, N.A., an industry leading financial enablement company, announced the promotion of Christopher Soupal to Commercial Finance Division President. He will report to Brett Pharr, co-president and Chief Operating Officer of MetaBank. Soupal brings more than 20 years of finance and capital management experience to the new role. He will lead all aspects of Commercial Finance, including the Crestmark and AFS/IBEX divisions as well as commercial operations. “Chris has shown a proven ability to expand our commercial finance business into niche sectors with innovative applications of our lending products,” said Pharr. “He is a true asset to our business, our clients, and is well-deserving of this new role.” Soupal joined Crestmark in 2014 as national sales director of the newly...

Continue reading

(“OKYO” or the “Company”) – OKYO Pharma Retains Ora Inc. to Perform Regulatory Development of OK-101 for Dry Eye Indications

LONDON and BOSTON, June 29, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, is pleased to announce that it has retained the services of Ora, Inc., a world-class ophthalmology contract research organization (“CRO”), to guide the company’s upcoming product development and lead the regulatory strategy of OK-101 for the treatment of dry eye. OK-101, OKYO’s lead pre-clinical compound is a novel long-acting GPCR-based anti-inflammatory drug candidate. Dry eye is a multifactorial disease that results in ocular discomfort and tear film instability that can lead to ocular surface damage. It is often a chronic problem, particularly in older adults, and is expected...

Continue reading

Vow ASA : Vow ASA awarded contract with French shipbuilder Chantiers de l’Atlantique for world largest cruise ship

Vow ASA has through its subsidiary Scanship been awarded a contract with the French shipyard Chantiers de l’Atlantique for the delivery of advanced wastewater purification system to be installed on the seventh newbuild for Royal Caribbean International Oasis class of ships. This newbuild is planned to be the largest cruise ship in the world when it launches in 2026. “This contract is a result of a more than 20 years cooperation with Chantiers de l’Atlantique and a true partnership with Royal Caribbean International within advanced wastewater purification. It also strongly signals a cruise industry planning for future growth with continuous focus on environmental sustainability and the health of our oceans”; says Vow ASA CEO Henrik Badin in a statement.For more information, please contact Henrik Badin, CEO, Vow ASATel: + 47 90 78 98 25Email:...

Continue reading

EMGS secures multi-client and late sale contracts

Electromagnetic Geoservices ASA (“EMGS” or the “Company”) is pleased to announce that the Company has secured an additional USD 1.2 million in prefunding for the upcoming Utsira High North Sea multi-client survey. The prefunding revenue is expected to be recognised in the fourth quarter of 2021. Additionally, the Company has also secured USD 0.8 million in late sales related to the North Sea multi-client data library. The late sale revenue will be recognised in the second quarter of 2021. CEO of EMGS, Bjørn Petter Lindhom, comments: “These new multi-client contracts and the previously announced international late sale frame agreement, further demonstrates the benefit and value-add of EMGS’ data and services for our customers, and the value of our existing multi-client library. Going forward, EMGS will continue to invest in new and financially...

Continue reading

L Brands Announces Proposed $500 Million Offering of Senior Notes Due 2029 by Its Spin-Off Subsidiary, Victoria’s Secret & Co.

COLUMBUS, Ohio, June 29, 2021 (GLOBE NEWSWIRE) — L Brands, Inc. (“L Brands”) (NYSE: LB) announced today that its subsidiary, Victoria’s Secret & Co. (“Victoria’s Secret”), is offering to sell $500 million aggregate principal amount of senior notes due 2029 (the “Notes”) in a private placement offering to eligible purchasers, subject to market and other conditions. Victoria’s Secret is a recently formed company, which L Brands intends to separate from its current business by means of a spin-off to its shareholders (the “Separation”). Upon the completion of the Separation, Victoria’s Secret intends to use the net proceeds from the offering of the Notes, after deducting discounts and commissions to the initial purchasers of the Notes and estimated offering expenses, to fund a portion of a cash payment to L Brands. Pending completion...

Continue reading

Disposal of stake in Semafone Ltd

Octopus Titan VCT plc (“Company” or “Titan”) 29 June 2021 Disposal of stake in Semafone Ltd The Board of Octopus Titan VCT plc is pleased to announce that Semafone Ltd has been acquired by Livingbridge. The exit represents an 8.5x return on Octopus Titan VCT plc’s initial investment, and a 7.5x return on the total investment, representing an IRR of 25%. The resulting cash proceeds attributable to Titan are not materially different from the value at which Titan currently holds its investment in Semafone. Semafone provides software to contact centres so they can collect personal data securely over various communication channels, including telephone and chat. Titan first invested in 2010 and participated in two further rounds of investment. Cumulatively, Titan invested £3.59m in Semafone. This demonstrates the important role that VCTs play...

Continue reading

WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth

Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021, represents a 102% sequential increase over Q4 2020, reflecting record sales of higher-margin, direct-to-consumer, and direct-to-patient productsReports significant improvement in SG&A expenses, down 66% from previous quarterGross Profit Before Fair Value Changes improved over $22 million sequentially from Q4 2020Adjusted EBITDA sequential improvement of over $31 million versus Q4 2020, reflecting improved gross profit and reduced expenses resulting from optimization initiativesManagement to host AGM on Wednesday, June 30th at 11:00 a.m. Eastern TimeTORONTO, June 29, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF)...

Continue reading

vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Poster Presentation on HPP737

HIGH POINT, N.C., June 29, 2021 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that it will be presenting data from the clinical development of HPP737 as a treatment for psoriasis in a poster presentation at the 6th World Psoriasis & Psoriatic Arthritis Conference held virtually June 30 – July 3, 2021 in Stockholm, Sweden. Poster Details:Poster Title: Pharmacokinetics and Pharmacodynamics of the Phosphodiesterase 4 (PDE4) Inhibitor HPP737 Following Single-dose Oral Administration in Healthy Subjects Presenting author: Aaron Burstein, PharmD ID: 35201 Topic: 4. Current and new therapeutic modalitiesThe poster will be added to vTv’s website following the presentation...

Continue reading

Auxly Announces Results of Annual General and Special Meeting of Shareholders

TORONTO, June 29, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) announced today the voting results from its annual general and special meeting of shareholders held on June 28, 2021 (the “Meeting”). A total of 132,758,409 common shares of the Company, representing 17.62% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders. All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s information circular dated May 20, 2021 (the “Circular”), were approved by the requisite majority of the votes cast at the Meeting. The results are set out below. Each of the directors listed as a nominee in the Circular was...

Continue reading

Midland and Probe Commence Drilling to Test New High-priority Targets South of Fenelon Gold

Figure 1Gaudet-Fenelon JVMONTREAL, June 29, 2021 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Probe Metals Inc. (“Probe”), is pleased to announce the start of an important drilling program to test new high-priority targets on the Gaudet-Fenelon project. This project is located less than 5 kilometres south of the Fenelon Gold project held by Wallbridge Mining Company Ltd and is a 50/50 joint venture between Midland and Probe. The Gaudet-Fenelon project covers more than 35 kilometres of favourable yet underexplored structures in the vicinity of the Lower Detour Fault, and is located immediately south of the Fenelon Gold deposit where Wallbridge is currently completing a resource estimate. Highlights:Regional geochemical surveys identified several new high-priority targets...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.